VibraCool Device for Pain After ACL Surgery
Trial Summary
What is the purpose of this trial?
The goal of this project is to test the effects of the VibraCool mechanical stimulation neuromodulatory therapeutic device on post-operative pain and opioid use following anterior crucitate ligament reconstruction (ACLR), and thus residual opioids in circulation.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
How does the VibraCool Device treatment differ from other treatments for pain after ACL surgery?
Eligibility Criteria
This trial is for individuals who have undergone ACL reconstruction surgery. It's not suitable for those who had pediatric IT band ACL reconstruction or non-English speakers due to the specific needs of the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the VibraCool device or comparator devices for post-operative pain management
Follow-up
Participants are monitored for pain levels and opioid use reduction
Treatment Details
Interventions
- VibraCool Device
VibraCool Device is already approved in United States for the following indications:
- Temporary relief of minor injuries (muscle or tendon aches)
- Treatment of myofascial pain post-surgery
- Use prior to or during physical therapy to treat myofascial pain caused by trigger points, restricted motion and muscle tension
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor